Use of pharmacogenomics in pediatric renal transplant recipients

por Medeiros, Mara, Castañeda-Hernández, Gilberto, Ross, Colin J. D., Carleton, Bruce C.
Publicado 2015

Hydroxyzine Use in Preschool Children and Its Effect on Neurodevelopment: A Population-Based Longitudinal Study

por Gober, Hans J., Li, Kathy H., Yan, Kevin, Bailey, Anthony J., Carleton, Bruce C.
Publicado 2022

A Systematic Review of Polygenic Models for Predicting Drug Outcomes

por Siemens, Angela, Anderson, Spencer J., Rassekh, S. Rod, Ross, Colin J. D., Carleton, Bruce C.
Publicado 2022

Benefits v. risks of COVID-19 vaccination: an examination of vaccination policy impact on the occurrence of myocarditis and pericarditis

por Carleton, Bruce C., Salmon, Daniel A., Ip, Patrick, Wong, Ian C.K., Lai, Francicso T.T.
Publicado 2023

Implementation of pharmacogenetic testing in oncology: DPYD-guided dosing to prevent fluoropyrimidine toxicity in British Columbia

por Wu, Angela, Anderson, Helen, Hughesman, Curtis, Young, Sean, Lohrisch, Caroline, Ross, Colin J. D., Carleton, Bruce C.
Publicado 2023

Pharmacogenetic variants in TPMT alter cellular responses to cisplatin in inner ear cell lines

por Bhavsar, Amit P., Gunaretnam, Erandika P., Li, Yuling, Hasbullah, Jafar S., Carleton, Bruce C., Ross, Colin J. D.
Publicado 2017

Exome sequencing pilot study in children with carbamazepine-induced serious skin reactions

por Amstutz, Ursula, Shyr, Casper, Shear, Neil H, Rieder, Michael J, Wasserman, Wyeth W, Ross, Colin J, Carleton, Bruce C
Publicado 2014

HLA-A*31:01 and HLA-B*15:02 as genetic markers for carbamazepine hypersensitivity in children

por Amstutz, Ursula, Ross, Colin J.D., Castro-Pastrana, Lucila I., Rieder, Michael J., Shear, Neil H., Hayden, Michael R., Carleton, Bruce C.
Publicado 2013

All-trans retinoic acid (ATRA) regulates key genes in the RARG-TOP2B pathway and reduces anthracycline-induced cardiotoxicity

por Hasbullah, Jafar S., Scott, Erika N., Bhavsar, Amit P., Gunaretnam, Erandika P., Miao, Fudan, Soliman, Hesham, Carleton, Bruce C., Ross, Colin J. D.
Publicado 2022

Pharmacogenomics of Vincristine‐Induced Peripheral Neuropathy Implicates Pharmacokinetic and Inherited Neuropathy Genes

por Wright, Galen E.B., Amstutz, Ursula, Drögemöller, Britt I., Shih, Joanne, Rassekh, Shahrad R., Hayden, Michael R., Carleton, Bruce C., Ross, Colin J.D.
Publicado 2018

Pharmacogenomics in Pediatric Patients: Towards Personalized Medicine

por Maagdenberg, Hedy, Vijverberg, Susanne J. H., Bierings, Marc B., Carleton, Bruce C., Arets, Hubertus G. M., de Boer, Anthonius, Maitland-van der Zee, Anke H.
Publicado 2016

Pharmacogenomic testing in paediatrics: Clinical implementation strategies

por Barker, Charlotte I. S., Groeneweg, Gabriella, Maitland‐van der Zee, Anke H., Rieder, Michael J., Hawcutt, Daniel B., Hubbard, Tim J., Swen, Jesse J., Carleton, Bruce C.
Publicado 2022

RBL2 Regulates Cardiac Sensitivity to Anthracycline Chemotherapy

por Xia, Peng, Chen, Jingrui, Sapkota, Yadav, Scott, Erika N., Liu, Yuening, Hudson, Melissa M., Rassekh, Shahrad R., Carleton, Bruce C., Ross, Colin J.D., Chow, Eric J., Cheng, Zhaokang
Publicado 2023

Transcriptome-wide association study uncovers the role of essential genes in anthracycline-induced cardiotoxicity

por Scott, Erika N., Wright, Galen E. B., Drögemöller, Britt I., Hasbullah, Jafar S., Gunaretnam, Erandika P., Miao, Fudan, Bhavsar, Amit P., Shen, Fei, Schneider, Bryan P., Carleton, Bruce C., Ross, Colin J. D.
Publicado 2021

Design and Methods of the Pan-Canadian Applying Biomarkers to Minimize Long-Term Effects of Childhood/Adolescent Cancer Treatment (ABLE) Nephrotoxicity Study: A Prospective Observa...

por McMahon, Kelly R., Rod Rassekh, Shahrad, Schultz, Kirk R., Pinsk, Maury, Blydt-Hansen, Tom, Mammen, Cherry, Tsuyuki, Ross T., Devarajan, Prasad, Cuvelier, Geoff D. E., Mitchell, Lesley G., Baruchel, Sylvain, Palijan, Ana, Carleton, Bruce C., Ross, Colin J. D., Zappitelli, Michael
Publicado 2017

Epidemiologic Characteristics of Acute Kidney Injury During Cisplatin Infusions in Children Treated for Cancer

por McMahon, Kelly R., Rassekh, Shahrad Rod, Schultz, Kirk R., Blydt-Hansen, Tom, Cuvelier, Geoffrey D. E., Mammen, Cherry, Pinsk, Maury, Carleton, Bruce C., Tsuyuki, Ross T., Ross, Colin J. D., Palijan, Ana, Huynh, Louis, Yordanova, Mariya, Crépeau-Hubert, Frédérik, Wang, Stella, Boyko, Debbie, Zappitelli, Michael
Publicado 2020

A Coding Variant in RARG Confers Susceptibility to Anthracycline-Induced Cardiotoxicity in Childhood Cancer

por Aminkeng, Folefac, Bhavsar, Amit P., Visscher, Henk, Rassekh, Shahrad R., Li, Yuling, Lee, Jong W., Brunham, Liam R., Caron, Huib N., van Dalen, Elvira C., Kremer, Leontien C., van der Pal, Helena J., Amstutz, Ursula, Rieder, Michael J., Bernstein, Daniel, Carleton, Bruce C., Hayden, Michael R., Ross, Colin J.D.
Publicado 2015

Outcome Definition Influences the Relationship between Genetic Polymorphisms of ERCC1, ERCC2, SLC22A2 and Cisplatin Nephrotoxicity in Adult Testicular Cancer Patients

por Zazuli, Zulfan, Otten, Leila S., Drögemöller, Britt I., Medeiros, Mara, Monzon, Jose G., Wright, Galen E. B., Kollmannsberger, Christian K., Bedard, Philippe L., Chen, Zhuo, Gelmon, Karen A., McGoldrick, Nicole, Kitchlu, Abhijat, Vijverberg, Susanne J. H., Masereeuw, Rosalinde, Ross, Colin J. D., Liu, Geoffrey, Carleton, Bruce C., Maitland-van der Zee, Anke H.
Publicado 2019

Genetic Determinants of Ototoxicity During and After Childhood Cancer Treatment: Protocol for the PanCareLIFE Study

por Clemens, Eva, Meijer, Annelot JM, Broer, Linda, Langer, Thorsten, van der Kooi, Anne-Lotte LF, Uitterlinden, André G, de Vries, Andrica, Kuehni, Claudia E, Garrè, Maria L, Kepak, Tomas, Kruseova, Jarmila, Winther, Jeanette F, Kremer, Leontien C, van Dulmen-den Broeder, Eline, Tissing, Wim JE, Rechnitzer, Catherine, Kenborg, Line, Hasle, Henrik, Grabow, Desiree, Parfitt, Ross, Binder, Harald, Carleton, Bruce C, Byrne, Julianne, Kaatsch, Peter, am Zehnhoff-Dinnesen, Antoinette, Zolk, Oliver, van den Heuvel-Eibrink, Marry M
Publicado 2019

Association between Genetic Variants and Cisplatin-Induced Nephrotoxicity: A Genome-Wide Approach and Validation Study

por Zazuli, Zulfan, de Jong, Corine, Xu, Wei, Vijverberg, Susanne J. H., Masereeuw, Rosalinde, Patel, Devalben, Mirshams, Maryam, Khan, Khaleeq, Cheng, Dangxiao, Ordonez-Perez, Bayardo, Huang, Shaohui, Spreafico, Anna, Hansen, Aaron R., Goldstein, David P., de Almeida, John R., Bratman, Scott V., Hope, Andrew, Knox, Jennifer J., Wong, Rebecca K. S., Darling, Gail E., Kitchlu, Abhijat, van Haarlem, Simone W. A., van der Meer, Femke, van Lindert, Anne S. R., ten Heuvel, Alexandra, Brouwer, Jan, Ross, Colin J. D., Carleton, Bruce C., Egberts, Toine C. G., Herder, Gerarda J. M., Deneer, Vera H. M., Maitland-van der Zee, Anke H., Liu, Geoffrey
Publicado 2021